stars 1 stars 2 stars 3

In January 2006, IVAX was acquired by Teva Pharmaceutical Industries Ltd., expanding into a unique company that has become the clear global leader in generic pharmaceuticals and a major player in the global healthcare industry. Teva Pharmaceutical Industries Ltd. (NYSE: TEVA) is a leading global pharmaceutical company, committed to increasing access to high-quality healthcare by developing, producing and marketing affordable generic drugs as well as innovative and specialty pharmaceuticals and active pharmaceutical ingredients. Headquartered in Israel, Teva is the world's leading generic drug maker, with a global product portfolio of more than 1,000 molecules and a direct presence in approximately 60 countries. Teva's Specialty Medicines businesses focus on CNS, respiratory oncology, pain, and women's health therapeutic areas as well as biologics. Teva currently employs approximately 45,000 people around the world and reached $20.3 billion in net revenues in 2013.

IVAX Questions

The IVAX annual revenue was $16.3 billion in 2026.

Marcela Carle is the R and D Director of IVAX.

7 people are employed at IVAX.

IVAX is based in Bangkok, Bangkok.

The NAICS codes for IVAX are [4241, 424, 42].

The SIC codes for IVAX are [51, 511].

G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users